Making the switch: a retrospective case series of our departmental experience of biosimilar medications

Koebner’s phenomenon and confetti lesions. Recent data suggest oral corticosteroids, that is, 4 mg dexamethasone twice weekly, narrow-band-UV phototherapy (three times per week), and topical clobetasol-propionate (five times per week), as the most efficient treatment option. Our patient refused oral corticosteroids. As she had a low Fitzpatrick skin phototype, we decided not to perform phototherapy but to treat her with topical corticosteroids followed by topical calcineurin inhibitors.